Vaxcyte, Inc.PCVXNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | -0.69% |
| Q3 2025 | 1.27% |
| Q2 2025 | -1.90% |
| Q1 2025 | 14.37% |
| Q4 2024 | 24.22% |
| Q3 2024 | 7.05% |
| Q2 2024 | 7.99% |
| Q1 2024 | 13.46% |
| Q4 2023 | 12.31% |
| Q3 2023 | 7.95% |
| Q2 2023 | 10.25% |
| Q1 2023 | 9.71% |
| Q4 2022 | 9.67% |
| Q3 2022 | 15.73% |
| Q2 2022 | 24.84% |
| Q1 2022 | 11.39% |
| Q4 2021 | 3.82% |
| Q3 2021 | 7.30% |
| Q2 2021 | 3.30% |
| Q1 2021 | 22.81% |
| Q4 2020 | -2.16% |
| Q3 2020 | 60.80% |
| Q2 2020 | -7.16% |
| Q1 2020 | 33.54% |
| Q4 2019 | -2.11% |
| Q3 2019 | 10.87% |
| Q2 2019 | 72.04% |
| Q1 2019 | 0.00% |